These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8077344)

  • 1. Leukemia after a small dose of radioiodine for metastatic thyroid cancer.
    Bitton R; Sachmechi I; Benegalrao Y; Schneider BS
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1423-6. PubMed ID: 8077344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute leukemias after treatment with radioiodine for thyroid cancer.
    Roldán Schilling V; Fernández Abellán P; Domínguez Escribano JR; Rivas González C; Mut Barberá E; Calatayud Cendra R
    Haematologica; 1998 Aug; 83(8):767-8. PubMed ID: 9793274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preleukemia following large dose radioiodide therapy for metastatic thyroid carcinoma.
    Yoosufani Z; Slavin JD; Hellman RM; Sethi SS; Spencer RP
    J Nucl Med; 1987 Aug; 28(8):1348-50. PubMed ID: 3612295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic myeloid leukaemia following 131I treatment for thyroid carcinoma: a report of two cases and review of the literature.
    Shimon I; Kneller A; Olchovsky D
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):651-4. PubMed ID: 8548952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases.
    Focosi D; Galimberti S; Petrini M
    Haematologica; 2007 Sep; 92(9):e96-7. PubMed ID: 17768141
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute myeloid leukemia after iodine-131 treatment for thyroid disorders.
    Laurenti L; Salutari P; Sica S; Piccirillo N; Zini G; Zollino M; Leone G
    Ann Hematol; 1998 Jun; 76(6):271-2. PubMed ID: 9692815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy-related acute promyelocytic leukemia after treatment with radioiodine for thyroid cancer: case report with literature review.
    Grudeva-Popova J; Yaneva M; Zisov K; Ananoshtev N
    J BUON; 2007; 12(1):129-32. PubMed ID: 17436415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma.
    Van Nostrand D; Atkins F; Yeganeh F; Acio E; Bursaw R; Wartofsky L
    Thyroid; 2002 Feb; 12(2):121-34. PubMed ID: 11916281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients.
    Schlumberger M; De Vathaire F; Ceccarelli C; Delisle MJ; Francese C; Couette JE; Pinchera A; Parmentier C
    J Nucl Med; 1996 Apr; 37(4):606-12. PubMed ID: 8691249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy-related acute myeloid leukemia following radioactive iodine treatment for thyroid cancer.
    Oluwasanjo A; Pathak R; Ukaigwe A; Alese O
    Cancer Causes Control; 2016 Jan; 27(1):143-6. PubMed ID: 26453198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Risk of Leukemia After Radioactive Iodine Therapy in Patients with Thyroid Cancer: A Nationwide, Population-Based Study in Korea.
    Seo GH; Cho YY; Chung JH; Kim SW
    Thyroid; 2015 Aug; 25(8):927-34. PubMed ID: 26133388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
    Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
    J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative frequency in which empiric dosages of radioiodine would potentially overtreat or undertreat patients who have metastatic well-differentiated thyroid cancer.
    Kulkarni K; Van Nostrand D; Atkins F; Aiken M; Burman K; Wartofsky L
    Thyroid; 2006 Oct; 16(10):1019-23. PubMed ID: 17042688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of bone marrow toxicity in elderly patients treated with recombinant human thyroid-stimulating hormone and empirically dosed radioiodine for thyroid cancer.
    Amdur RJ; Dan T; Mazzaferri E
    Am J Clin Oncol; 2013 Aug; 36(4):348-53. PubMed ID: 22547013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic myeloid leukemia after treatment with 131 for thyroid carcinoma.
    Wang KL; Lin LY; Chen PM; Lin HD
    J Chin Med Assoc; 2005 May; 68(5):230-3. PubMed ID: 15909729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic myeloid leukemia in a man with papillary carcinoma of the thyroid treated with radioactive iodine.
    Pavithran K; Doval DC
    Am J Clin Oncol; 2005 Apr; 28(2):216. PubMed ID: 15803020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The carcinogenic effects of radioiodine therapy for thyroid carcinoma.
    de Vathaire F
    Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):180-1. PubMed ID: 18283326
    [No Abstract]   [Full Text] [Related]  

  • 18. Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients.
    Bal CS; Kumar A; Pant GS
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1666-73. PubMed ID: 15070929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 131I therapy of thyroid cancer patients.
    Reiners C; Farahati J
    Q J Nucl Med; 1999 Dec; 43(4):324-35. PubMed ID: 10731783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.